2017 Archived Content

演讲者

  • Kathleen Abadie, Engineer I, Late Stage Pharmaceutical Development, Genentech
  • Ahmad M. Abdul-Fattah, Ph.D., Senior Scientist, Lyophilization Unit, Coriolis Pharma
  • Prasad S. Adusumilli, M.D., FACS, Deputy Chief, Thoracic Service, Memorial Sloan Kettering Cancer Center
  • Teri Aldrich, Ph.D., Principal Investigator, Bio-Process Development, ZymoGenetics, a Bristol-Myers Squibb Co.
  • Spencer Alford, Ph.D., Protein Engineer, xCella Biosciences, Inc.
  • Richard Altman, MS, Scientist, Protein Technologies, Amgen
  • Nadia Amharref, Ph.D., Scientist, Cell Line Development, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH
  • Bradley D. Anderson, Ph.D., Professor, Pharmaceutical Sciences, University of Kentucky
  • Frances Arnold, Ph.D., Dickinson Professor of Chemical Engineering, Bioengineering and Biochemistry, California Institute of Technology
  • Tara Arvedson, Ph.D., Director, Oncology Research, Amgen, Inc.
  • Fouad Atouf, Ph.D., Director, Global Biologics, United States Pharmacopeia (USP)
  • Yves Aubin, Ph.D., Research Scientist, Regulatory Research Division, Health Canada
  • Jean Aucamp, Ph.D., Principal Scientist, Technology Development, Novel Biological Entities, Novartis Pharma AG
  • Chris Bailey-Kellogg, Ph.D., Professor, Computer Science, Dartmouth University
  • Nitin S. Baliga, MSc, Ph.D., Professor, Senior Vice President & Director, Institute for Systems Biology
  • Ashok D. Bandaranayake, Ph.D., Director, Bioprocess Development, Peptide Drug Discovery Initiative, Fred Hutchinson Cancer Research Center
  • Jeffrey E. Barrick, Ph.D., Assistant Professor, Molecular Biosciences, The University of Texas at Austin
  • William Barrett, Ph.D., Product Specialist- Chromatography, Gore PharmBIO Products, Gore & Associates
  • Amrik Basran, CSO, Therapeutics, Avacta Life Sciences
  • Anton Bauer, Ph.D., COO, The Antibody Lab GmbH
  • Paul Belcher, Ph.D., Functional Leader, Biacore™, GE Healthcare
  • Itai Benhar, Ph.D., Professor, Biotechnology, Tel Aviv University
  • David B. Berkowitz, Ph.D., Willa Cather Professor of Chemistry, Department of Chemistry, University of Nebraska
  • Basar Bilgicer, Ph.D., Associate Professor, Chemical and Biomolecular Engineering, University of Notre Dame
  • Murali Bilikallahalli, Ph.D., Associate Director, Formulation Sciences, Proteins, Vaccines & Oligos, MedImmune
  • Ruben J. Boado, Ph.D., Vice President and Co-Founder, ArmaGen, Inc.
  • Berthold Boedeker, Ph.D., Chief Scientist, Global Biologics Development, Bayer Pharma AG
  • Kevin Bonham, Ph.D., Lecturer, Microbiology and Immunobiology Department, Harvard Medical School
  • Carlo Boutton, Ph.D., Director, Technology & Information Management, Ablynx nv
  • Katherine Bowers, Ph.D., Principal Scientist/Group Leader, Analytical and Formulation Development, FUJIFILM Diosynth Biotechnologies
  • Andrew M. Bradbury, Ph.D., MB, BS, Staff Scientist, Biosciences, Los Alamos National Laboratory
  • James Brady, Ph.D., Director, Technical Applications, MaxCyte, Inc.
  • Neil D. Brewis, Ph.D., CSO, F-star Biotechnology, Ltd.
  • Adrian Briggs, Juno
  • Ulrich Brinkmann, Ph.D., Expert Scientist, Pharma Research & Early Development, Roche Innovation Center Munich
  • Niket Bubna, Senior Scientist, Process Development, KBI Biopharma
  • Karen Bunting, Ph.D., Science Director, Molecular Biology & Fermentation, Albumedix Ltd.
  • Michael Burke, Senior Research Chemist, Bench Research
  • Johannes Felix Buyel, Ph.D., Head, Integrated Production Platforms; Fraunhofer Institute for Molecular Biology and Applied Ecology IME
  • Julio A. Camarero, Ph.D., Associate Professor, Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California
  • Keith A. Canada, Ph.D., Director, Chemical Biotechnology, Head of Protein Engineering, Merck Research Laboratories
  • Anne Carpenter, Ph.D., Director, Imaging Platform, Broad Institute
  • John F. Carpenter, Ph.D., Professor, Pharmaceutical Sciences; Co-Director, Center for Pharmaceutical Biotechnology, University of Colorado Anschutz Medical Center
  • Sean Carroll, Ph.D., Scientist, Atreca
  • Mikael Bjerg Caspersen, Ph.D., Customer Solution Science Manager, Albumedix Ltd.
  • Javier Chaparro-Riggers, Ph.D., Director, Antibody Technology, Pfizer
  • Stephen Chappell, Ph.D., Scientific Director, Promosome, LLC
  • Shangchiung Chen, Ph.D., Scientist, Clinical Pharmacology, Genentech
  • Henry C. Chiou, Ph.D., Associate Director, Cell Biology, Life Science Solutions, Thermo Fisher Scientific
  • Byung-Kwan Cho, Ph.D., Associate Professor, Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST)
  • Danny Chou, Ph.D., President and Founder, Compassion BioSolution; Former Senior Research Scientist, Biologics Development, Gilead Sciences
  • Claudio Ciferri, Ph.D., Scientist, Structural Biology, Genentech
  • William Clay Brown, Ph.D., Associate Research Scientist and Scientific Director, High-Throughput Protein Lab, Center for Structural Biology/Life Sciences Institute, University of Michigan
  • Jennifer R. Cochran, Ph.D., Associate Professor, Bioengineering, Stanford University
  • Steve Comeau, Ph.D., Bioinformatics Architect, Research & Non-Clinical Development Informatics, Shire
  • Ken Davis, Member, Biophorum Operations Group (BPOG)
  • Antonin De Fougerolles, Ph.D., CSO, Ablynx NV
  • Barthélemy Demeule, Ph.D., Senior Scientist & Senior Group Leader, Late Stage Pharmaceutical Development, Genentech
  • Allison Derenne, Ph.D., Researcher, Structure and Function of Biological Membranes, Universit蒙 libre de Bruxelles
  • Shrikant Deshpande, Ph.D., Senior Director, Protein Chemistry, Biologics Discovery California, Bristol-Myers Squibb Co.
  • John Desjarlais, Ph.D., Chief Scientific Officer, Xencor
  • Iskandar Dib, Ph.D., Principal R&D Manager, Process Development & Analytics, VTU Technology GmbH
  • Dimiter S. Dimitrov, Ph.D., Senior Investigator, Protein Interactions Section, Cancer and Inflammation Program, National Cancer Institute
  • Rakesh Dixit, Ph.D., DABT, Vice President, Research & Development, and Global Head, Biologics Safety Assessment, MedImmune (A member of AstraZeneca Group)
  • Neil Dixon, Ph.D., BBSRC Fellow, MIB, University of Manchester
  • John Dresios, Ph.D., Chief Scientist and Technical Fellow, Leidos, Inc.
  • Keren Drori, Ph.D., Product Manager, Marketing, Protein Science, Takara Bio USA, Inc.
  • Stefan Dübel, Ph.D., Professor and Head, Biotechnology, Technische Universität Braunschweig
  • Yves Durocher, Ph.D., Section Head, Mammalian Cell Expression - NRC Human Health Therapeutics Portfolio, National Research Council Canada
  • Thomas E. Edwards, Ph.D., Vice President, Structural Biology, Beryllium Discovery Corp
  • Adam Elhofy, Ph.D., CSO, Essential Pharmaceuticals LLC
  • Mikael Elias, Ph.D., Assistant Professor, Biochemistry, Molecular Biology and Biophysics, University of Minnesota
  • Mark Ellis, Principal Scientist, Protein Expression and Purification, UCB Pharma
  • Sam Ellis, Vice President & Biochemist,Thomson Instrument Company
  • Hans Erickson, Ph.D., Associate Director, Protein Chemistry, Genentech
  • Dominic Esposito, Ph.D., Director, Protein Expression Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc.
  • Bram D. Estes, Scientist, Amgen
  • Michael Evans, Ph.D., Assistant Professor, Radiology and Biomedical Imaging, University of California, San Francisco
  • Louis Fabri, Director, Protein Technologies, Research, CSL Limited
  • Yongliang Fang, Researcher, Thayer School of Engineering, Dartmouth College
  • Joachim Feldwisch, Ph.D., Director, Preclincal Development, Research, Affibody AB
  • Marina Feschenko, Ph.D., Principal Scientist, Analytical Development, Biogen
  • Nicolas Fischer, Ph.D., Director, Research, NovImmune SA, Switzerland
  • Mike Fleming, Scientist, Analytical and Pharmaceutical Sciences, ImmunoGen, Inc.
  • Andrew Fosberry, Ph.D., Senior Scientific Investigator, Protein and Cellular Sciences, GlaxoSmithKline plc
  • Jeremy Fry, D.Phil., Director, Sales, ProImmune
  • Tyler Gadoury, Engineer, Manufacturing Technology, Bristol-Myers Squibb Co.
  • Rui Gan, Ph.D., Research Associate, Michael C. Jewett Laboratory, Chemical and Biological Engineering, Northwestern University
  • Bernhard H. Geierstanger, Ph.D., Director, Protein Engineering, Genomics Institute of the Novartis Research Foundation
  • William Gillette, Ph.D., Principal Scientist, RAS Protein Production, and Deputy Director, Protein Expression Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research (FNL)
  • Pierre-Alain Girod, Ph.D., Chief Scientific Officer, Selexis
  • Lori Giver, Ph.D., Vice President, Biological Engineering, Calysta
  • David Glover, Senior Engineer, Purification Development, Genentech
  • Adam Goldstein, MSc, Principal Scientist, Global Technology, Roche/Genentech
  • Ulf Grawunder, Ph.D., CEO & Founder, NBE-Therapeutics, Ltd.
  • Christopher Gray, Ph.D., Structural Biology Team Leader, Drug Discovery Program, CRUK Beatson Institute
  • Elizabeth Greene, MS, Scientist, Immune Modulation and Biotherapeutics Discovery (IMBD), Boehringer Ingelheim
  • Jane Gross, Ph.D., Vice President, Research and Non-Clinical Development, Emergent Biosolutions
  • Zhenyu Gu, Ph.D., Development Scientist III, Early Assay Development, Alexion Pharmaceuticals
  • Rosanne Guijt, Ph.D., Alexander von Humboldt Fellow and Senior Lecturer, Australian Centre for Research on Separation Science (ACROSS), University of Tasmania
  • Martin Gustavsson, Ph.D., Staff Scientist, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego
  • Lin He, Ph.D., Senior Application Scientist, Bioinformatics Solutions, Inc.
  • Torsten Hechler, Ph.D., Head, Biochemistry and ADC Research, Heidelberg Pharma
  • Charles Heffern, Application Specialist, NanoTemper Technologies
  • Alexander P. Herbert, Senior Process Engineer, Process Engineering and Pilot Plant, West-Ward Pharmaceuticals
  • Christoph Herwig, Ph.D., Professor, Head, Research Division, Biochemical Engineering, Vienna University of Technology
  • Amy Hilderbrand, Ph.D., Technical Development Scientist, Protein Analytical Chemistry, Genentech
  • Oliver Hill, Ph.D., Vice President, Molecular Biology Apogenix GmbH, Germany
  • Tim Hitchman, Ph.D., Director, Innovation, DSM Food Specialties
  • Mitchell Ho, Ph.D., Senior Investigator and Chief, Antibody Therapy Section, Laboratory of Molecular Biology, National Cancer Institute, NIH
  • Robert Holt, Ph.D., Head of Sequencing, Michael Smith Genome Sciences Center, BC Cancer Agency, Canada
  • Karen Holt-Tiffin, Ph.D., Head, Biocatalysis, Dr. Reddy's Laboratories Ltd.
  • Elizabeth E. Hood, Ph.D., CEO, Infinite Enzymes, LLC, Distinguished Professor of Agriculture, Arkansas State University
  • Michael Hornsby, Ph.D., Researcher, UCSF Antibiome and Recombinant Antibody Network, Pharmaceutical Chemistry, University of California, San Francisco
  • Desmond G. Hunt, Ph.D., Senior Scientific Liaison, Standards Development, United States Pharmacopeia (USP)
  • Jiyoung Hwang, MSc, Associate Scientist, Biology, Gilead Sciences
  • Gregory C. Ippolito, Ph.D., Research Assistant Professor, Molecular Biosciences, The University of Texas at Austin
  • Michael Ignatov, Ph.D., Senior Scientist, Biologics Development Analytical Sciences, Allergan, Plc
  • Eric Isberg, Member, Change Notification and User Specification Groups, The Bio-Process Systems Alliance (BPSA)
  • Renaud Jacquemart, Ph.D., Author, BioProcess International
  • Alexander Jarasch, Ph.D., Life Science Business Consultant, Quattro Research GmbH, Germany
  • Donald L. Jarvis, Ph.D., Professor, Molecular Biology, University of Wyoming; President, GlycoBac, LLC
  • Dennis Jenke, Ph.D., Distinguished Scientist, R&D, Baxter Healthcare Corporation
  • Jan Jezek, Ph.D., CSO, Development, Arecor Ltd.
  • Guifeng Jiang, Ph.D., Senior Manager, Analytical Science, Boehringer Ingelheim
  • Syd Johnson, Ph.D., Vice President, Antibody Engineering, MacroGenics, Inc.
  • Aled Jones, Ph.D., Senior Product Manager, ProZyme, Inc
  • Alois Jungbauer, Ph.D., Professor, Laboratory of Protein Technology and Downstream Processing, Austrian Center of Biotechnology, Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU)
  • Beth Junker, Ph.D., Principal Consultant, BioProcess Advantage LLC
  • Meelis Kadaja, Ph.D., MBA, Director, Business Development, Icosagen Technologies Inc.
  • Sohye Kang, Ph.D., Senior Scientist, Process Development, Amgen
  • Raghuraman Kannan, Ph.D., Associate Professor, Radiology and BioEngineering, University of Missouri School of Medicine
  • Sambit Kar, Ph.D., Principal Scientist; Head, Biophysics Center of Excellence, Molecular & Analytical Development, Bristol-Myers Squibb Co.
  • Kerry Kelleher, MS, MSCIS, Senior Principal Scientist, Biomedicines Design, Pfizer
  • Donald E. Kerkow, Ph.D., Associate Director, Biopharmaceutical Development, KBI Biopharma Inc.
  • Bruce Kerwin, Ph.D., ??/span>Vice President, Drug Product Design, Just Biotherapeutics
  • Marina Kirkitadze, Ph.D., MBA, Deputy Director, Analytical R&D Biochemistry, Sanofi Pasteur
  • Francis Kinderman, Ph.D., Senior Scientist, Drug Product and Formulation Technologies, Amgen
  • Georg Klima, Dipl. Ing., Executive Director, Process Science, Boehringer Ingelheim RCV GmbH & Co KG
  • Hendrik Knoetgen, Ph.D., Program Leader, Targeted Therapeutics, Roche Pharma Research and Early Development, F. Hoffmann-La Roche, Ltd.
  • James T. Koerber, Ph.D., Scientist, Antibody Engineering, Genentech
  • Manfred Konrad, Ph.D., Research Director, Enzyme Biochemistry, Max Planck Institute for Biophysical Chemistry
  • Amit Kumar, Ph.D., Graduate of Michael Betenbaugh's Lab, Johns Hopkins University; Postdoctoral Research Fellow, Chemical and Molecular Biology, St. Jude Children's Research Hospital
  • T.K.S. Kumar, Ph.D., Professor, Chemistry & Biochemistry, University of Arkansas
  • Roshan Kumar, Group Leader, Cambridge Site, HiFiBiO, Inc.
  • Steve LaBrenz, Ph.D., Scientific Director, Janssen R&D LLC
  • John M. Lambert, Ph.D., Executive Vice President & Distinguished Research Fellow, ImmunoGen, Inc.
  • James Lambropoulos, MS, Engineer III, Cell Culture Development, Biogen
  • Thomas Laue, Ph.D., Professor, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire
  • Holger Laux, Ph.D., Fellow, Integrated Biologics Profiling, Novartis/Technical Development NBE
  • Heehyoung Lee, Ph.D., ??/span>Director, Target Discovery and Validation, LA Cell, Inc.
  • Russ Lehrman, Ph.D., President/Founder, R&D Consultation, BioSuperior Technology
  • Kristin Lenberg, Global Product Marketing Manager, ÄKTA™ lab-scale systems, Product Management, GE Healthcare
  • Nathan E. Lewis, Ph.D., Assistant Professor, Pediatrics, University of California, San Diego
  • Chunze Li, Ph.D., Senior Scientist, Therapeutic Area Lead for ADCs, Clinical Pharmacology, Genentech
  • Jinjiang Li, Ph.D., Senior Principal Scientist, Drug Product Science & Technology, Bristol-Myers Squibb Co.
  • Kim Li, Ph.D., DABT, MPH,, Senior Manager, Environment, Health, Safety and Sustainability Product Stewardship Toxicology, Amgen
  • "Gary" Guiyang Li, Ph.D., Senior Scientist, Attribute Science, Amgen
  • Yunsong (Frank) Li, Principal Scientist, Analytical and Formulation Development, Cook Pharmica
  • Zhiyu Li, Ph.D., Associate Professor, Pharmaceutical Sciences, Philadelphia College of Pharmacy
  • Martin Linhult, Ph.D., Head, Bio100 Line 1, Biopharmaceuticals, Octapharma
  • Liming Liu, D.Phil., Principal Scientist, Pharmacokinetics, Pharmacodynamics and Drug Metabolism (PPDM), Merck Research Laboratory
  • James Love, Ph.D., Director, Expression Technologies, Protein Expression, ATUM (formerly DNA2.0)
  • Noelle Lombana, Ph.D., Senior Scientific Researcher, Antibody Engineering, Genentech
  • Kerry Routenberg Love, Ph.D., Research Associate & Technical Program Manager, InSCyT Program, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • Ray Low, Ph.D., Scientist, Biologics Optimization, Amgen
  • Xiaofeng Lu, Ph.D., Principal Research Scientist, AbbVie Biotherapeutics Inc.
  • Lawrence G. Lum, M.D., D.Sc., Professor, Medicine, Director, Cellular Therapy, and Scientific Director, BMT, University of Virginia
  • Quanzhou Luo, Ph.D., Senior Scientist, Process Development, Amgen
  • Julian Ma, Ph.D., Hotung Chair of Molecular Immunology, Institute for Infection and Immunity, St. George's Hospital Medical School, University of London
  • Hideaki Mabashi-Asazuma, Ph.D., Research Scientist, Molecular Biology, University of Wyoming
  • Scott Mack, Staff Development Scientist, ProteinSimple
  • Atsuhiko Maeda, Ph.D., Research Scientist, Pharmaceutical Technology, Chugai Pharmaceutical Co., Ltd., Japan
  • Sheila G. Magil, Ph.D., Senior Consultant, BioProcess Technology Consultants, Inc.
  • Haripada Maity, Ph.D., Research Advisor, Formulation Development, Eli Lilly and Company
  • Greg Manley, Ph.D., Senior Applications Scientist, Unchained Labs
  • Sylvain Marcel, Ph.D., Senior Scientist, Molecular Biology, iBio CMO
  • James D. Marks, M.D., Ph.D., Chief of Staff, Chief of Anesthesia, San Francisco General Hospital; Professor & Vice Chairman of Anesthesia, University of California San Francisco
  • Radhakrishna Maroju, Ph.D., Senior Scientist, Drug Product Development and Operations, Teva Biopharmaceuticals
  • Jerold Martin, MSc, Chairman, BPSA BoD and Technology (E+L) Committee
  • Nobuyuki Matoba, Ph.D., Associate Professor, Department of Pharmacology and Toxicology, James Graham Brown Cancer Center, University of Louisville School of Medicine
  • Yariv Mazor, Ph.D., Scientist, Antibody Discovery & Protein Engineering, MedImmune
  • Adam McCullough, ??/span>Principal Engineer, Advanced Device Technologies, Amgen
  • Timothy R. McCoy, MSc.,?枉rincipal Scientist, Technical Development, Sanofi Ireland
  • Karen A. McDonald, Ph.D., Professor, Chemical Engineering, University of California, Davis
  • Michael Meagher, Ph.D., Vice President, Therapeutics Production & Quality, St. Jude Children's Research Hospital
  • David Meininger, Ph.D., Chief Business Officer, Trianni, Inc.
  • Eric Meinke, Ph.D., Senior Scientist, AstraZeneca Supply Biologics
  • Stefano Menegatti, Ph.D., Assistant Professor, Chemical and Biomolecular Engineering, North Carolina State University
  • David Miao, Ph.D., CSO, Concortis Biotherapeutics
  • Jason Micklefield, Ph.D., FRSC, Professor of Chemical Biology, University of Manchester
  • Ana Moreno, Research Scientist, Bioengineering, University of California, San Diego
  • Phil Morton, Ph.D., Science Director, Bioprocess Characterisation, Albumedix Ltd.
  • Jonathan Mott, MS, Process Development Engineer, Amunix Operating
  • Claudia Mueller, Ph.D., Senior Scientist, Late-Stage Pharmaceutical and Processing Development, Pharmaceutical Development & Supplies, F. Hoffmann-La Roche Ltd., Switzerland
  • Dirk Müller, Ph.D., Head, R&D Services, Insilico Biotechnology AG
  • Sophia T. Mundle, Ph.D., Deputy Director, Protein Chemistry, Sanofi Pasteur
  • Somen Nandi, Ph.D., Managing Director, Global HealthShare® Initiative, Department of Molecular & Cellular Biology, University of California
  • Yasser Nashed-Samuel, Ph.D., Principal Scientist, Attribute Sciences, Process Development, Amgen
  • David Nicoli, Ph.D., Vice President, Research & Development, Particle Sizing Systems, LLC
  • Dennis Niermeier, MSc, Scientist, IBA GmbH - Solutions For Life Sciences
  • Zivko Nikolov, Ph.D., P.E., Dow Professor, Biological and Ag Engineering, National Center for Therapeutic Manufacturing, Texas A&M University
  • David O'Connell, Ph.D., Lecturer & Director, Biomolecular & Biomedical Science, University College Dublin, and Founder, YourProteome
  • Bernhard Palsson, Ph.D., Galletti Professor, Bioengineering; Principal Investigator, Systems Biology Research Group, Bioengineering; Professor, Pediatrics, University of California, San Diego
  • Paul W.H.I. Parren, Ph.D., Senior Vice President & Scientific Director, Genmab A/S
  • Diane Paskiet, MS, Senior Director, Global Scientific Affairs, West Pharmaceutical Services
  • Brian Paszkiet, MS, Staff Scientist, Cell Biology, Life Sciences Solutions, Thermo Fisher Scientific
  • Sandip P. Patel, M.D., Assistant Professor, Cancer Immunotherapy Program, Experimental Therapeutics, Thoracic Oncology, Moores Cancer Center, University of California, San Diego
  • Michael Pauly, Ph.D., CSO, Mapp Biopharmaceuticals
  • David Pearlman, Ph.D., Senior Principal Scientist, Schrödinger
  • Didier Pertuy, Vice President, Global Drug Device Integrated Development, Sanofi, France
  • Michael Pikal, Ph.D., Distinguished Endowed Chair in Pharmaceutical Technology & Professor, Department of Pharmaceutics, University of Connecticut
  • Lucille Pourcel, Ph.D., Postdoc Laboratory, Molecular Biology, University of Lausanne
  • Gerard Powell, Ph.D., Senior Principal Specialist, Product Characterisation, Analytical Sciences, Allergan Biologics Ltd.
  • Dennis Powers, Director, Sales Engineering, G-CON Manufacturing
  • Justin Prien, Ph.D., Associate Director, Analytical Development, Shire
  • Jinshu Qiu, Ph.D., Principal Scientist, Process Development, Amgen
  • Christoph Rader, Ph.D., Associate Professor, Cancer Biology and Molecular Therapeutics, The Scripps Research Institute
  • Arvind Rajpal, Ph.D., Vice President, Protein Therapeutics, Bristol-Myers Squibb Co.
  • Vangipuram S. Rangan, Ph.D., Senior Director, Protein Chemistry, Bristol-Myers Squibb Co.
  • Anokha Ratnayake, Ph.D., Principal Scientist, Medicine Design - ADC Oncology, Pfizer
  • Benno Rattel, Ph.D., Executive Director, Nonclinical Development ARM, AMGEN Research (Munich) GmbH
  • Sai Reddy, Ph.D., Assistant Professor, Biosystems Science and Engineering, ETH Zurich, Switzerland
  • Jörg Thomas Regula, Ph.D., Head, Functional Characterization, pRED Large Molecule Research, Roche Diagnostics GmbH
  • Frank J. Riske, Ph.D., Senior Consultant, BioProcess Technology Consultants
  • Richard Rogers, Ph.D., Scientist 4, Just Biotherapeutics
  • Floyd Romesberg, Ph.D., Professor, Chemistry, The Scripps Research Institute
  • David Rozzell, Ph.D., Senior Vice President, Biocatalysis, Provivi, Inc.
  • Joseph Rucker, Ph.D., Vice President, Research & Development, Integral Molecular
  • Michael A. Ruberto, Ph.D., President, Material Needs Consulting, LLC
  • Ekneet Sahni, Ph.D., Senior Process Development Engineer, Manufacturing Science and Technology (MSAT), Pfizer
  • Wendy Saffell-Clemmer, MS, Director, Research, Pharmaceutical Development, Baxter Healthcare
  • Frank Sainsbury, Ph.D., Associate Group Leader, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland
  • Krishnan Sampath, Ph.D., ??/span>Senior Director, Drug Product Sciences, MacroGenics, Inc.
  • Catherine Sanders, Ph.D., Director, Scientific Liaisons, Adaptive Biotechnologies
  • Fumihiko Sato, Ph.D., Professor, Division of Integrated Life Science, Graduate School of Biostudies, Kyoto University
  • Giovanna Scapin, Ph.D., Principal Scientist, Structural Chemistry, Merck & Co., Inc.
  • Andreas Schaaf, Ph.D., CSO, Greenovation Biotech GmbH
  • Jonas V. Schaefer, Ph.D., Head, High-Throughput Binder Selection Facility, Biochemistry, University of Zurich
  • David A. Scheinberg, M.D., Ph.D., Vincent Astor Chair, and Chairman, Molecular Pharmacology Program, Sloan Kettering Institute
  • Tilman Schlothauer, Ph.D., Principal Scientist, Biochemical and Analytical Research, Large Molecule Research, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Penzberg, Germany
  • Stefan R. Schmidt, Ph.D., MBA, Vice President, Rentschler Biotechnology
  • Birgit Schoeberl, Ph.D.,  Head of Discovery, Senior Vice President, Merrimack
  • Sebastian Schuck, Head, Business Development, Wacker Biotech GmbH
  • Manfred Schuster, Ph.D., CEO, RMB-Research
  • Evgenyi Shalaev, Ph.D., Research Investigator, Pharmaceutical Development, Allergan
  • Nigel Shipston, Ph.D., Director, Program Design, FUJIFILM Diosynth Biotechnologies
  • Satish Singh, Head, Drug Product Process Development, Lonza
  • Thomas Slaney, Ph.D., Scientist I, Molecular and Analytical Development, Global Manufacturing & Supply, Biologics Development & Operations, Bristol-Meyers Squibb Co.
  • Stephen G. Sligar, Ph.D., Director, Swanlund Endowed Chair, Molecular and Cellular Biology, The University of Illinois
  • Vaughn Smider, Ph.D., Assistant Professor, Molecular Biology, Scripps Research Institute; CSO, Sevion Therapeutics
  • Pauline Smidt, Process Development Scientist, Just Biotherapeutics
  • Christopher Smith, Ph.D., Senior Scientific Consultant, Biologics, Genedata
  • Christoph Spiess, Ph.D., Senior Scientist, Antibody Engineering, Genentech
  • Eileen Spindler, Ph.D., Director, R&D Innovation, Muse Biotechnology
  • Nicola Stagg, Ph.D., Scientist/Toxicologist, Safety Assessment, Genentech
  • Rainer Stahn, Ph.D., Director, Process Development, Glycotope GmbH
  • Robert St. Onge, Ph.D., Senior Research Scientist, Stanford Genome Technology Center, Stanford University
  • William R. Strohl, Ph.D., Vice President and Head, BioTherapeutics, Janssen R&D, Pharmaceutical Companies of Johnson & Johnson
  • Raj Suryanarayanan, Ph.D., Professor, Peters Endowed Chair, Department of Pharmaceutics, University of Minnesota
  • Eric Tam, Ph.D., Principal Scientist, Antibody Engineering, Merrimack Pharmaceuticals, Inc.
  • Serguei Tchessalov, Ph.D., Associate Research Fellow, Biotherapeutics Pharmaceutical Research & Development, Pfizer, Inc.
  • Peter M. Tessier, Ph.D., Associate Professor, Chemical & Biological Engineering, Rensselaer Polytechnic Institute
  • T.N. Thompson, President, Millrock Technology, Inc.
  • Nels Thorsteinson, Scientific Services Manager, Biologics, Chemical Computing Group
  • Mark Throsby, Ph.D., Executive Vice President & CSO, Merus B.V.
  • Alessandra Tieri, Ph.D., Researcher Scientist, Protein Chemistry, Analytical Development, Merck
  • Dorin Toader, Ph.D., Senior Scientist, Antibody Discovery and Protein Engineering, MedImmune LLC
  • Danielle Tullman-Ercek, Ph.D., Department of Chemical and Biological Engineering, Northwestern University
  • Daniel Tus蒙, Ph.D., Managing Director, DT/Consulting Group
  • Renata Varga, Ph.D., Characterization Scientist, Analytical Sciences, Global Biological CMC, Teva Pharmaceuticals
  • Olga Vasiljeva, Ph.D., Associate Director, Head of Protease Biology, CytomX Therapeutics
  • Karthik Veeravalli, Ph.D., Senior Engineer, Late Stage Cell Culture, Genentech
  • Alexey Veraksa, Ph.D., Associate Professor, Biology, University of Massachusetts, Boston
  • Anne Verhagen, Ph.D., Group Leader, Cellular Biochemistry, CSL Limited
  • Christina Vessely, Ph.D., Senior Consultant, Biologics Consulting Group
  • Renaud Vincentelli, Ph.D., Head, Protein Production, Structural Biology Facility, CNRS Univ Aix Marseille I & II
  • Bjørn Voldborg, MSc, Director, CHO Cell Line Development, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
  • Moritz von Stosch, Ph.D., Lecturer, School of Chemical Engineering and Advanced Materials, Newcastle University
  • Lawrence P. Wackett, Ph.D., McKnight Professor, Biochemistry, Molecular Biology and Biophysics, University of Minnesota
  • Geoffrey Waldo, Ph.D., Team Leader, Los Alamos National Laboratory
  • Cornelia Walther, Ph.D., Scientist, Biotechnology, University of Natural Resources and Life Sciences Vienna (BOKU)
  • John Wang, Ph.D., FAAPS, Principal Scientist, Genentech
  • Ouwei Wang, Ph.D., John D. Coates Laboratory, Energy Biosciences, University of California, Berkeley
  • Scott Waniger, Vice President, Bioservices, Cell Culture Company
  • Nicholas Warne, Ph.D., Senior Director, Pharmaceutical R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer
  • Yanzhang Wei, Ph.D., Professor, Biological Sciences, Clemson University
  • Matthew Weinstock, Scientist II, Research Systems, Synthetic Genomics
  • Mark Welch, Ph.D., Vice President, Research and Development, ATUM (formerly DNA2.0)
  • Yingxia Wen, Ph.D., Director and Head, Protein Biochemistry, Research, Seqirus, a CSL Company
  • Lindsay Wegiel, Ph.D., Research Scientist I, Pharmaceutical Development, Baxter
  • John Wheeler, Principal Research Scientist, Janssen BioTherapeutics
  • Sajith Wickramasekara, Founder and CEO, Benchling
  • Gavin Williams, Ph.D., Associate Professor, Chemistry, North Carolina State University
  • John Williams, Ph.D., Professor, Molecular Medicine, Director, X-Ray Core Facility, Beckman Institute, City of Hope
  • Gerhard Winter, Ph.D., Professor, Chair, Pharmaceutical Technology and Biopharmaceutics, LMU Munchen
  • Athena Wong, Ph.D., Senior Scientist & Senior Group Leader, Early Stage Cell Culture, Genentech
  • Ken Wong, Deputy Director, Process Technology, Sanofi Pasteur
  • Sam Wu, Ph.D., Principal Scientist, Biologics Research, Janssen BioTherapeutics
  • Mingjie Xie, Co-founder and CEO, Rapid Novor Inc
  • Yingda Xu, Ph.D., Associate Director, Protein Analytics, Adimab LLC
  • Yan-ping Yang, Ph.D., Senior Director and Head, Bioprocess R&D North America, Sanofi Pasteur
  • Alexei Yeliseev, Ph.D., Staff Scientist, Laboratory of Membrane Biochemistry and Biophysics, NIAAA, NIH
  • Xingxing Zang, M.Med., Ph.D., Miriam Mandel Faculty Scholar in Cancer Research Associate Professor, Microbiology & Immunology, Albert Einstein College of Medicine
  • Edward R. Zartler, Ph.D., Senior Group Leader, Biophysics, Analytical R&D, Pfizer
  • Jingtao Zhang, Ph.D., Principal Scientist, Pharmaceutical Sciences, Merck Research Laboratories
  • Qinghai Zhang, Ph.D., Associate Professor, Integral Structural and Computational Biology, The Scripps Research Institute
  • Jiang Zhu, Ph.D., Assistant Professor, Department of Immunology and Microbial Science, Department of Integrative Structural and Computational Biology, Scripps Research Institute
  • Ting Zhu, Ph.D., Investigator & Associate Professor, School of Life Sciences, Tsinghua University
  • Bryan Zimdahl, Ph.D., Research Scientist, Preclinical Development, Eureka Therapeutics Inc.
  • Jonathan Zmuda, Director, Cell Biology, Thermo Fisher Scientific